Tracy Curley, CFO and interim CEO at iSpecimen
Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More
iSpecimen
How Medical Researchers Can Leverage Tech to Help Streamline Biospecimen Matchmaking and Procurement
Many medical advancements – from life-saving vaccines and treatments to new diagnostic tests like liquid biopsies – are built on research that involves human biospecimens. Biofluids, tissue and cells are indispensable resources for the medical researcher, yet the process of sourcing these biospecimens can be woefully frustrating and inefficient. These challenges can have a direct, negative impact on the pace of discovery, creating urgency for improved access to the biospecimens researchers need
Read More
Biospecimen Procurement for R&D Needs to Look More Like an Online Marketplace
As healthcare digitizes everything from insurance claims to clinical decisions, some functions remain frustratingly analog, old school, and inefficient.
One such function is the distribution of human biospecimens necessary for medical research. Specimens are essential in providing much of the data that researchers examine, EHRs capture, and scientific databases aggregate. Unfortunately, the distribution of specimens and their data to researchers is woefully outdated and inefficient. Frankly,
Read More
iSpecimen Launches First Online Marketplace for Human Biospecimens
iSpecimen, a Lexington, MA-based startup has launched the iSpecimen Marketplace, an online, data-rich platform that connects life science researchers who need human biospecimens to the healthcare organizations that have them. Using a powerful, multi-faceted search platform, the marketplace enables medical researchers to intuitively search millions of available human biospecimens and solves one of the research industry’s biggest challenges – how to compliantly obtain quality biospecimens in a
Read More
Mayo Clinic, iSpecimen Collaborate on Cancer/Normal Serum Biobank
Mayo Clinic Center for Individualized Medicine has selected iSpecimen, a customized human biospecimen collections company to serve as the exclusive channel partner for the Mayo Clinic Cancer/Normal Serum Biobank, connecting biomedical researchers with the samples and associated data for their studies. Mayo Clinic Cancer/Normal Serum Biobank OverviewBased in Rochester, Minnesota, the Cancer/Normal Serum Biobank has approximately 130,000 frozen vials of serum from about 17,000 unique, consented
Read More
